114 related articles for article (PubMed ID: 11106643)
61. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.
Sheikh MS; Li XS; Chen JC; Shao ZM; Ordonez JV; Fontana JA
Oncogene; 1994 Dec; 9(12):3407-15. PubMed ID: 7970699
[TBL] [Abstract][Full Text] [Related]
62. Regulation of the c-met proto-oncogene promoter by p53.
Seol DW; Chen Q; Smith ML; Zarnegar R
J Biol Chem; 1999 Feb; 274(6):3565-72. PubMed ID: 9920903
[TBL] [Abstract][Full Text] [Related]
63. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
64. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
65. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.
Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR
J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752
[TBL] [Abstract][Full Text] [Related]
66. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
67. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
Ahn JY; Chung EY; Kwun HJ; Jang KL
Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
[TBL] [Abstract][Full Text] [Related]
68. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T
Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890
[TBL] [Abstract][Full Text] [Related]
70. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53.
Tang HY; Zhao K; Pizzolato JF; Fonarev M; Langer JC; Manfredi JJ
J Biol Chem; 1998 Oct; 273(44):29156-63. PubMed ID: 9786925
[TBL] [Abstract][Full Text] [Related]
71. The murine-reduced folate carrier gene can act as a selectable marker and a suicide gene in hematopoietic cells in vivo.
Liu S; Song L; Bevins R; Birhiray O; Moscow JA
Hum Gene Ther; 2002 Sep; 13(14):1777-82. PubMed ID: 12396629
[TBL] [Abstract][Full Text] [Related]
72. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
[TBL] [Abstract][Full Text] [Related]
73. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
Kelavkar UP; Badr KF
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
[TBL] [Abstract][Full Text] [Related]
74. Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines.
Sharif KA; Moscow JA; Goldman ID
Biochem Pharmacol; 1998 May; 55(10):1683-9. PubMed ID: 9634005
[TBL] [Abstract][Full Text] [Related]
75. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
76. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
77. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
Idelman G; Glaser T; Roberts CT; Werner H
J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
[TBL] [Abstract][Full Text] [Related]
78. Repression of BRCA1 through a feedback loop involving p53.
MacLachlan TK; Dash BC; Dicker DT; El-Deiry WS
J Biol Chem; 2000 Oct; 275(41):31869-75. PubMed ID: 10884389
[TBL] [Abstract][Full Text] [Related]
79. Mechanism and regulation of folate uptake by human pancreatic epithelial MIA PaCa-2 cells.
Nabokina SM; Ma TY; Said HM
Am J Physiol Cell Physiol; 2004 Jul; 287(1):C142-8. PubMed ID: 14998787
[TBL] [Abstract][Full Text] [Related]
80. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
